Consumer Health

In 2023, Australians suffered from an extended influenza season, with months where people were prone to sickness. Analgesics had already seen strong growth in the last few years due to widespread illness as a result of COVID-19.However, strong growth…

Analgesics continued to see solid growth in current value terms in 2023, following the easing of most COVID-19-related restrictions in September 2022. With measures such as lockdowns, mandatory mask-wearing and social distancing no longer in place,…

With the ending of lockdowns, border closures, and other COVID-19-related restrictions over the course of 2022, Australia has begun to see a return to normality in 2023, with Australians settling into their new hybrid routines and lifestyles.…

The consumer health industry in New Zealand continued to witness robust growth in current value terms in 2023. The year marked a return to a semblance of normality in the country, following the reopening of borders and the lifting of COVID-19…

Australia has been impacted by an extended season of colds and flu in 2023, with many Australians becoming ill. As the lockdowns and COVID-19 restrictions were lifted, people no longer followed social distancing, and fewer Australians have been…

With an early start to the influenza season, many New Zealanders were caught off guard and succumbed to the virus throughout 2023. With a dry cough being one of the most common flu symptoms, demand for treatments to help soothe the throat was…

Dermatologicals is set to see a strong performance in 2023, with all the major categories seeing mid to high single-digit growth in retail current value terms. Antifungals (topical antifungals and vaginal antifungals) is one of the largest categories…

Topical antifungals was one of the most dynamic subcategories within dermatologicals in current value terms in 2023, continuing the trend of the previous year. Following a sluggish performance during the first three years of the review period, such…

Rising inflation in 2023 is placing downwards pressure on disposable incomes in Australia, which is having a significant impact on discretionary spending. While there is still robust interest in dietary supplements, such products are expensive, and…

Retail sales of dietary supplements in New Zealand saw stronger growth in current value terms in 2023. However, much of this was driven by increases in unit prices, due to inflation, rather than any significant upturn in demand. The country high…

Diarrhoeal remedies is set to see solid growth in Australia in 2023, with more Australians finding themselves in need of such products compared with previous years. Australians are spending more time outside the home, and are once again vulnerable to…

The increasing propensity of consumers to dine out, following the ending of COVID-19 restrictions, triggered a rise in demand for digestive remedies in New Zealand in 2023, continuing the trend that was seen during the second half of the previous…

Eye health is an ongoing concern for Australians, with this worsening for many people over the last five years. With rates of chronic eye conditions such as myopia increasing amongst consumers, there is growing demand for eye care products to help…

Eye health is a major global concern with short-sightedness (myopia) affecting people from a younger age. This is thought to be due to lifestyle factors, including reduced exposure to sunlight, and the propensity of the population to spend more time…

Demand for herbal/traditional products is set to continue to rise in 2023, driven by the health and wellness trend. As consumers seek to reduce their exposure to artificial ingredients and chemicals, Australians are becoming more and more interested…

The health and wellness trend continued to fuel demand for herbal and traditional products in 2023. Local consumers actively sought out products they perceived as more natural in an effort to reduce their exposure to chemicals. Herbal and traditional…

Australians have become increasingly aware of the negative side-effects associated with smoking, with information being widely available online, and also due to warnings on cigarette packets. The persistent efforts from the Australian government to…

Demand for NRT smoking cessation aids remained strong in New Zealand in 2023, amidst a consistent decline in the prevalence of smoking in the country. According to Euromonitor data, an estimated 12% of adults in New Zealand smoked on a daily basis in…

Compared with previous years, the rate of vaccination for children in Australia has declined in 2023, leaving the younger demographic more vulnerable to colds and flu. Given the nation endured an extended influenza season, sickness amongst children…

Paediatric consumer health saw continued growth in current value terms in 2023. This was due, in part, to a higher number of cases of colds and flu, with the influenza B virus, which spread throughout most of 2023, being particularly harmful for…